Why the study?
Anxiety is associated with increased risk of incident CHD and poor cardiac prognosis, but the underlying pathophysiological mechanisms and biomarkers remain poorly defined.
Do specific biomarkers explain the increased risk of coronary heart disease in patients with anxiety disorders compared to controls?
Do specific biomarkers explain the increased risk of coronary heart disease in patients with anxiety disorders compared to controls?
Myocardial perfusion and coronary artery calcium are plausible biomarkers linking anxiety to increased CHD risk, though data remains very limited and further studies are needed.
Answers are grounded in this paper and cite their sources.
Mechanisms linking anxiety/depression to CHD lack robust evidence; leaves open targeted original studies to define pathophysiology.
Anxiety is the most common mental health disorder in the United States, affecting nearly a third of the population. As for depression, it is associated with increased risk of incident coronary heart disease (CHD) and poor cardiac prognosis. The pathophysiological mechanism underlying this "deleterious" association is not well defined. While several hypotheses have been proposed, few seem proven in original studies. A narrative literature review was thus performed to identify all original studies that looked at any biomarkers that can be implicated in the relation between anxiety and CHD. Surprisingly, only four cohorts or observational studies on anxiety and CHD reported biophysiopathological variables. Of the overall populations studied, only 15% were women. In term of biomarkers, plasma lipid levels, C-reactive protein, cortisol, norepinephrine, body mass index, blood pressure and heart rate variability were mostly not significantly different between anxious patients and controls. Only two variables, myocardial perfusion and coronary artery calcium, were found different between the two groups. In summary, underlying biomarkers explaining the increased risk of CHD in anxious patients are still poorly understood. Although based on very limited data, myocardial perfusion and coronary artery calcium seem to be plausible biomarkers. Clearly, more studies are needed to better understand this problematic, especially in women. This step is essential so that personalized care for patients with both anxiety and CHD can be implemented.
No takes yet. Share an insight, caveat, or question.
Judith Brouillette (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: